Who's calling? https://live.nida.edu.au/oxybutynin-and-jogging-ekud oxybutynin er tab 10 mg Patients taking sugammadex to reverse deep paralysis causedby rocuronium emerged, on average, in 2.2 minutes, according topooled data from late-stage clinical trials conducted by Merckand submitted to the FDA. Patients taking neostigmine emerged in19 minutes, while those taking a placebo emerged in 92.9minutes.
(携帯) |